Clinical trial
Treatment of Latent TB Infection for Jailed Persons
NCT00128206 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00128206 |
|---|---|
| Title | Treatment of Latent TB Infection for Jailed Persons |
| Official title | Clinical Trial of Short Course Rifampin Versus INH for LTBI in Jail |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Isoniazid, Rifampin |
| Enrollment | 364 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Aug 9, 2005 |
| Last update posted | Jul 21, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: